Patent classifications
C
C12
C12Y
207/00
C12Y207/11
C12Y207/11007
C12Y207/11007
CAMK2D ANTISENSE OLIGONUCLEOTIDES AND USES THEREOF
20210378652
·
2021-12-09
·
The present disclosure relates to antisense oligonucleotides, which target CAMK2D mRNA in a cell, leading to reduced expression of CAMK2D protein. Reduction of CAMK2D protein expression is beneficial for the treatment of certain medical disorders, e.g., cardiovascular-related diseases or disorders.